1. Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort study. (January 2022) Authors: Mahil, Satveer K; Bechman, Katie; Raharja, Antony; Domingo-Vila, Clara; Baudry, David; Brown, Matthew A; Cope, Andrew P; Dasandi, Tejus; Graham, Carl; Khan, Hataf; Lechmere, Thomas; Malim, Michael H; Meynell, Freya; Pollock, Emily; Sychowska, Kamila; Barker, Jonathan N; Norton, Sam; Galloway, Jam... Journal: Lancet Issue: Volume 4:Number 1(2022) Page Start: e42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study. (September 2021) Authors: Mahil, Satveer K; Bechman, Katie; Raharja, Antony; Domingo-Vila, Clara; Baudry, David; Brown, Matthew A; Cope, Andrew P; Dasandi, Tejus; Graham, Carl; Lechmere, Thomas; Malim, Michael H; Meynell, Freya; Pollock, Emily; Seow, Jeffery; Sychowska, Kamila; Barker, Jonathan N; Norton, Sam; Galloway, J... Journal: Lancet Issue: Volume 3:Number 9(2021) Page Start: e627 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗